Immunobiology of cystic echinococcosis

Parassitologia

Volumn 46, Issue 4, 2004, Pages 375-380

  Conchedda, M ^a,b   Gabriele, F ^a   Bortoletti, G ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Dipartimento di Scienze Applicate ai Biosistemi   (Italy)

Author keywords

Avoidance strategies; Cystic echinococcosis; Experimental secondary hydatidosis; Human infection; Immune response

Indexed keywords

CYTOKINE; HELMINTH ANTIBODY; NITRIC OXIDE; PARASITE ANTIGEN;

ANIMAL; ANIMAL DISEASE; CATTLE; CATTLE DISEASE; COMPLEMENT ACTIVATION; CONFERENCE PAPER; ECHINOCOCCOSIS; ECHINOCOCCUS; GROWTH, DEVELOPMENT AND AGING; HOST PARASITE INTERACTION; HUMAN; IMMUNOLOGY; LARVA; MOUSE; PARASITOLOGY; PERMEABILITY; PHYSIOLOGY; TH1 CELL; TH2 CELL; ULTRASTRUCTURE;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CATTLE; CATTLE DISEASES; COMPLEMENT ACTIVATION; CYTOKINES; ECHINOCOCCOSIS; ECHINOCOCCUS; HOST-PARASITE RELATIONS; HUMANS; LARVA; MICE; NITRIC OXIDE; PERMEABILITY; TH1 CELLS; TH2 CELLS;

EID: 23644450610     PISSN: 00482951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (62)

1. Aminzhanov M (1976). The biology of hydatids in sheep. Veterinariya Moscow 7: 68-70.
2. Ayuya JM, Williams JF (1979). The immunological response of the rat to infection with Taenia taeniaeformis. VII Immunization by oral and parenteral administration of antigens. Immunol 36: 825-834.
3. Baz A, Carol H, Marco M, Casabò L, Jones F, Dunne D, Nieto A (1998). Fc-binding molecules specific for human IgG1 and IgG3 are present in Echinococcus granulosus protoscoleces. Parasite Immunol 20: 399-404.
4. Bortoletti G, Conchedda M (1983). Immunità passiva nel topo: danni associati all'azione di sieri diversi trasferiti prima e dopo l'infestazione con Taenia taeniaeformis. Parassitologia 25 (2-3): 212-215.
5. Bortoletti G, Piredda G, Palmas C, Conchedda M (1983). Damage and destruction of Taenia taeniaeformis larvae transplanted intraperitoneally in rats immunized against the parasite or its usual host (mouse). Microbios Letters 24: 153-158.
6. Bortoletti G, Conchedda M, Ferretti G (1985). Damage and early destruction of Taenia taeniaeformis larvae in resistant hosts, and anomalous development in susceptible hosts: a light microscopic and ultrastructural study. Int J Parasitol 15(4): 377-384.
7. Bortoletti G, Ferretti G (1985). Morphological studies on the early development of Taenia taeniaeformis larvae in susceptible mice. Int J Parasitol 15: 365-375.
8. Bortoletti G, Cagetti M, Gabriele F, Conchedda M. (2002). Morphological variability and degenerative evolution of human hepatic hydatid cysts. Parassitologia 44: 159-171.
9. Bortoletti G, Gabriele F, Conchedda M (2005). Natural history of Cystic Echinococcosis in humans. Parassitologia, in press.
10. Bresson-Hadni S, Liance M, Meyer JP, Houin R, Bresson JL, Vuitton DA (1990). Cellular immunity in experimental Echinococcus multilocularis infection. II. Sequential and comparative phenotypic study of the periparasitic mononuclear cells in resistant and sensitive mice. Clin Exp Immunol 82: 378-383.
11. Campbell DH (1936). Active immunization of albino rats with protein fractions from Taenia taeniaeformis and its larval form Cysticercus fasciolaris. Am J Hyg 23: 104-113.
12. Campbell DH (1938). The specific absorbability of protective antibodies against Cysticercus crassicollis in rats and C pisiformis in rabbits from infected and artificially immunized animals. J Immunol 35: 205-216.
13. Coltorti EA, Varela-Diaz VM (1974). Echinococcus granulosus. Penetration of macromolecules and their localization on the parasite membranes of cysts. Exp Parasitol 35: 225-231.
14. Conchedda M, Ferretti G (1983). Vaccination of susceptible hosts with uninfective strains of the same parasite (Taenia taeniaeformis, Cestoda) provide protection against an infective strain. J Parasitol 69(6): 1166-1167.
15. Conchedda M, Ferretti G (1984). Susceptibility of different strains of mice to various levels of infection with the eggs of Taenia taeniaeformis. Int J Parasitol 14(6): 541-546.
16. Conchedda M, Bortoletti G, Capra S, Ecca AR, Gabriele F, Palmas C (1998). Immune response to Echinococcus granulosus: cytokines during early secondary experimental hydatidosis in mice. Parassitologia 40 (Suppl 1): 35.
17. Conchedda M, Bortoletti G, Ecca AR, Gabriele F, Palmas C (2001). Study on immunobiology in endoparasites of public health interest: Echinococcosis- Hydatidosis. Parassitologia 43 (Suppl 1): 11-19.
18. Conchedda M, Cagetti M, Gabriele F, Nardello O, Serra P, Bortoletti G (2004). Combined morpho-structural, clinical and immunological study of cystic hydatidosis. Preliminary results. Parassitologia 46 (Suppl 1): 133.
19. Craig PS (1993). Immunodiagnosis of Echinococcus granulosus. In: Compendium on CE with special references to the Xinjiang Uygur Autonomous Region, the People's Republic of China. Brigham Young University, Provo, UT, Andersen FL Ed, pp 85-118.
20. Conchedda M, Marongiu L, Masnata G, Caddeo F (1988). Studio comparato immunologico e clinico-strumentale di soggetti sardi adulti e giovani già sottoposti ad intervento per Idatidosi. Parassitologia 30: 56-57.
21. D'Amelio R, de Rosa F, Pontesilli O, Dayal R, Brighouse G, Teggi A, Barnet M, Lambert PH (1989). Hydatid disease: analysis of parasitic antigens in circulating immune complexes and in preformed hydatid Ag-Ab complexes. Med Microb Immun 178: 177-184.
22. Dematteis S, Pirotto F, Marqués J, Nieto A, Örn A, Baz A (2001). Modulation of the cellular immune response by a carbohydrate rich fraction from Echinococcus granulosus protoscoleces in infected or immunized Balb/C mice. Parasite Immunol 23: 1-9.
23. Dempster RP, Harrison GB, Berridge MV, Heath DD (1992). Echinococcus granulosus: use of an intermediate host mouse model to evaluate sources of protective antigens and a role to antibody in the immune response. Int J Parasitol 22: 435-441.
24. Dixon JB, Jenkins P (1995). Immunology of mammalian metacestode infections. I. Antigens, protective immunity and immunopathology. Helm Abstr 64: 533-542.
25. Ferragut G, Nieto A (1996). Antibody response of Echinococcus granulosus infected mice: recognition of glucidic and peptidic epitopes and lack of avidity maturation. Parasite Immunol 18: 393-402.
26. Gemmell MA (1962). Natural and acquired immunity factors inhibiting penetration of some hexacanth embryos. Nature 194: 701-702.
27. Gemmell MA (1964). Species specificity of the immunogenic complexes of the tapeworm hexacanth embryo. Nature 204: 705-707.
28. Gemmell MA (1966). Immunological responses of the mammalian host against tapeworm infection. IV. Species specificity of hexacanth embryos in protecting sheep against Echinococcus granulosus. Immunol 11: 325-335.
29. Gemmell MA (1967). Species specificity and cross-protective functional antigens of the tapeworm embryo. Nature 213: 500-501.
30. Gemmell MA, Soulsby EJ (1968). The development of acquired immunity to tapeworms and progress towards active immunization, with special reference to Echinococcus spp. Bull WHO 39: 45-55.
31. Gemmell MA, Lawson JR, Roberts MG (1987). Population dynamics in echinococcosis and cysticercosis. Evaluation of the biological parameters of Taenia hydatigena and Taenia ovis and comparison with those of Echinococcus granulosus. Parasitol 94: 161-180.
32. Heath DD, Jensen O, Lightowlers MW (2003). Progress in control of hydatidosis using vaccination. A review of formulation and delivery of the vaccine and recommendations for practical use in control programmes. Acta Trop 85: 133-143.
33. Irigoin F, Wurzner R, Sim RB, Ferreira AM (1996). Comparison of complement activation in vitro by different Echinococcus granulosus extracts. Parasite Immunol 18(7): 371-5.
34. Kassis Al, Tanner CE (1976). The role of complement in hydatid disease: in vitro studies. Int J Parasitol 6: 25-35.
35. Kwa BH, Liew FY (1977). Immunity in taeniasis-cysticercosis. I. Vaccination against Taenia taeniaeformis in rats using purified antigen. J Exp Med 146: 118-131.
36. Lightowlers MW, Rickard MD, Honey RD (1986). Serum Ab response following parenteral immunization with hydatid cyst fluid in sheep infected with Echinococcus granulosus. Am J Trop Med Hyg 35: 818-823.
37. Lightowlers MW, Lawrence SB, Gauci C, Young J, Ralston M, Mass D, Heath DD (1996). Vaccination against hydatidosis using a defined recombinant antigen. Parasite Immunol 18: 457-462.
38. Lightowlers MW, Jensen O, Fernandez E, Iriarte JA, Woollard DJ, Gauci C, Jenkins DJ, Heath DD (1999). Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep. Int J Parasitol 29: 531-534.
39. Lightowlers MW, Heath DD (2004). Immunity and vaccine control of Echinococcus granulosus infection in animal intermediate hosts. Parassitologia 46: 27-31.
40. MacIntyre AR, Dixon JB, Bleakley JS, Green JR (2000). Echinococcus granulosus: assays for hydatid immunoregulatory factors using established lymphoid cell lines. Parasite Immunol 22: 475-485.
41. MacIntyre AR, Dixon JB, Green JR (2001). Mitosis and differentiation in T-cells under cytotoxic action of Echinococcus granulosus hydatid fluid. Veterinary Parasitol 96: 277-289.
42. Miguez M, Baz A, Nieto A (1996). Carbohydrates on the surface of Echinococcus granulosus protoscoleces are immuno-dominant in mice. Parasite Immunol 18: 559-569.
43. Rajasekariah GR, Mitchell GF, Rickard MD (1980a). Taenia taeniaeformis in mice: protective immunization with oncospheres and their products. Int J Parasitol 10: 155-160.
44. Rajasekariah GR, Rickard MD, Mitchell GF (1980b). Immunization of mice against infection with Taenia taeniaeformis using various antigens prepared from eggs, oncospheres, developing larvae and strobilocerci. Int J Parasitol 10: 315-324.
45. Rajasekariah GR, Rickard MD, Mitchell GF, Anders RF (1982). Immunization of mice against infection with Taenia taeniaeformis using solubilized oncospheral antigens. Int J Parasitol 12: 111-116.
46. Rickard MD, Bell KJ (1971). Immunity produced against Taenia ovis and T. taeniaeformis infection in lambs and rats following in vivo growth of their larvae in filtration membrane diffusion chambers. J Parasitol 57: 571-575.
47. Riley EM, Dixon JB, Kelly DF, Cox DA (1985). The immune response to Echinococcus granulosus: sequential histological observations of lymphoreticular and connective tissues during early murine infection. J Comparative Pathol 95: 93-104.
48. Riley EM, Dixon JB, Jenkins P, Ross G (1986). Echinococcus granulosus infection in mice: host responses during primary and secondary infection. Parasitology 92: 391-403.
49. Riley EM, Dixon JB (1987). Experimental Echinococcus granulosus infection in mice: immunocytochemical analysis of lymphocyte populations in local lymphoid organs during early infection. Parasitology 94: 523-532
50. Riganò R, Profumo E, Ioppolo S, Notargiacomo S, Ortona E, Teggi A, Siracusano A (1995). Immunological markers indicating the effectiveness of pharmacological treatment in human hydatid disease. Cl Exp Immunol 102: 281-285
51. Riganò R, Profumo E, Ioppolo S, Notargiacomo S, Teggi A, Siracusano A (1999). Serum cytokine detection in the clinical follow up of patients with cystic echinococcosis. Cl Exp Immunol 115: 503-507.
52. Riganò R, Profumo E, Bruschi F, Carulli G, Azarà A, Ioppolo S, Buttari B, Ortona E, Margutti P, Teggi A, Siracusano A (2001). Modulation of human immune response by Echinococcus granulosus Antigen B and its possible role in evading host defences. Infect Immun 69: 288-296.
53. Rogan MT, Craig PS, Zehyle G, Masinde H, Wen H, Zhou P (1992). In vitro killing of taeniid oncospheres, mediated by human sera from hydatid endemic areas. Acta Trop 51: 291-296.
54. Sakamoto T, Cabrera PA (2003). Immunohistochemical observations on cellular response in unilocular hydatid lesions and lymph nodes of cattle. Acta Trop 85: 271-279.
55. Severi M, Ferragut G, Nieto A (1997). Antibody response to Echinococcus granulosus infected mice: Protoscolex specific response during infection is associated with decreasing specific IgG1/IgG3 ratio as well as decreasing avidity. Parasite Immunol 19: 545-552.
56. Shepherd JC, Aitken A, McManus DP (1991). A protein secreted in vivo by Echinococcus granulosus inhibits elastase activity and neutrophil chemotaxis. Mol Biochem Parasitol 44: 81-90.
57. Steers NJR, Rogan MT, Heath S (2001). In-vitro susceptibility of hydatid cysts of Echinococcus granulosus to nitric oxide and the effect of the laminated layer on nitric oxide production. Parasite Immunol 23: 411-417.
58. Sterla S, Sato H, Nieto A (1999). Echinococcus granulosus human infection stimulates low avidity anticarbohydrate IgG2 and high avidity antipeptide IgG4 antibodies. Parasite Immunol 21: 27-34.
59. Sweatman GK, Willimas RJ, Moriarty KM, Henshall TC (1963) On acquired immunity to Echinococcus granulosus in sheep. Res Vet Sci 4: 187-198.
60. Touil-Boukoffa C, Bauvois B, Sanceau J, Hamrioui B, Wietzerbin J (1998). Production of nitric oxide (NO) in human hydatidosis: relationship between nitrite production and interferon-gamma levels. Biochimie 80: 739-744.
61. Vuitton DA, Bresson-Hadni S, Laroche L, Kaiserlian D, Guerret-Stocker S, Bresson JL, Gillet M (1989). Cellular immune response in Echinococcus multilocularis infection in humans. II. Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis. Cl Exp Immunol 78: 67-74.
62. Yarulin GR (1968). Study of the development of hydatid cysts during experimental infection of lambs. Moscow: Izdat Akad Nauk SSST: 378-382.